Cognitive Impairment Clinical Trial
Official title:
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
The initial phase of substance abuse treatment is a vulnerable period for relapse. Cognitive impairments are common during this phase and may reduce the ability to benefit from other forms of substance abuse and rehabilitation services. The study compares a rehabilitation program that combines work therapy with computer-based cognitive training of attention, memory and executive functions to work therapy alone in a 3 months outpatient substance abuse program. It is hypothesized that cognitive training will increase days of sobriety during the active intervention and better substance abuse outcomes at 6 month follow-up.
This proposal aims to pilot test a cognitive remediation therapy (CRT) combined with work
therapy (WT) as an adjunct to the initial phase of outpatient substance abuse treatment.
There is ample research evidence of cognitive impairment across substance abuse disorders,
particularly in the early phase of recovery. Cognitive impairment has been associated with
poorer substance abuse treatment outcomes and may be remediated through programs of
exercises that target these impairments. The investigators have previously reported on a
model of providing CRT with work therapy (WT) in an outpatient context for people with
psychotic disorders, which showed significant improvements in executive function and working
memory, and in important functional outcomes such as work performance and sustained work
activity. The investigators propose to apply this same approach to a sample of participants
recruited from a 30-day residential program for substance abusers who are beginning their
recovery. When they are discharged, they will be able to continue WT, which may encourage
their engagement in CRT and in substance abuse outpatient services.
Our Specific Aims are: 1. Test the feasibility and tolerability of CRT & WT in the early
phase of substance abuse treatment. 2. Obtain effect size for CRT & WT compared to WT alone
on a primary substance abuse outcome measure (Days of Use) for a future R01 RCT submission.
3. Obtain effect sizes for secondary outcomes (e.g. neurocognition).
The investigators propose to accomplish these aims by randomizing 50 participants who wish
to receive WT services into two conditions: 25 will be assigned to 15 hours of WT plus 5
hours of CRT each week (CRT+WT) and 25 will be assigned to an active control of 20 hours of
WT. The active intervention will be for 13 weeks. CRT will be comprised of a repetitive
training on a hierarchy of progressive visual and auditory exercise from Positscience. WT
will involve paid work activity in a placement of their choosing on the medical center
campus. Participants will be paid the same hourly rate (half federal minimum wage) for their
time in CRT and WT. Comprehensive assessments will be performed at intake, 3 months and 6
months. These will include substance abuse, cognitive, and psychosocial outcomes as well as
adherence to treatment. During the 3 months of active intervention participants will have
weekly observed urine toxicology screens, breathalyzer tests and PDA assessments, as well as
monthly work performance evaluations. Data analyses will include random effects regression
models, as well as models of moderator and mediator effects on the primary outcome of PDA.
If meaningful effects are found, these results will guide a subsequent R01 submission.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Recruiting |
NCT04356924 -
Psychological Treatment to Support the Consequences of Cognitive Impairment
|
N/A | |
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Terminated |
NCT04493957 -
Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT04426838 -
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
|
N/A | |
Completed |
NCT04713384 -
Remote Bimanual Virtual Rehabilitation Post CVD
|
N/A | |
Recruiting |
NCT06284213 -
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
|
||
Recruiting |
NCT06053775 -
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)
|
N/A | |
Completed |
NCT03698695 -
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05552729 -
Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT03301402 -
Air Purifier to Improve Endothelial Function and Carotid Intima Thickness
|
N/A | |
Completed |
NCT03187353 -
IMProving Executive Function Study
|
Phase 4 | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Recruiting |
NCT04907565 -
Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
|
||
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Recruiting |
NCT05030285 -
Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment
|
N/A |